-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Pyxis Oncology, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q3 2020 to Q3 2024.
- Pyxis Oncology, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$23.8M, a 6.31% increase year-over-year.
- Pyxis Oncology, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$67.2M, a 34.4% increase year-over-year.
- Pyxis Oncology, Inc. annual Operating Income (Loss) for 2023 was -$82.2M, a 33.4% increase from 2022.
- Pyxis Oncology, Inc. annual Operating Income (Loss) for 2022 was -$123M, a 77.1% decline from 2021.
- Pyxis Oncology, Inc. annual Operating Income (Loss) for 2021 was -$69.7M, a 441% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)